These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38363995)

  • 1. Management of ventricular tachycardias: insights on centre settings, procedural workflow, endpoints, and implementation of guidelines-results from an EHRA survey.
    Sultan A; Futyma P; Metzner A; Anic A; Richter S; Roten L; Badertscher P; Conte G; Chun JKR
    Europace; 2024 Feb; 26(2):. PubMed ID: 38363995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey.
    Tilz RR; Lenarczyk R; Scherr D; Haugaa KH; Iliodromitis K; Pürerfellner H; Kiliszek M; Dagres N
    Europace; 2018 Jan; 20(1):209-213. PubMed ID: 29186419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
    Cronin EM; Bogun FM; Maury P; Peichl P; Chen M; Namboodiri N; Aguinaga L; Leite LR; Al-Khatib SM; Anter E; Berruezo A; Callans DJ; Chung MK; Cuculich P; d'Avila A; Deal BJ; Della Bella P; Deneke T; Dickfeld TM; Hadid C; Haqqani HM; Kay GN; Latchamsetty R; Marchlinski F; Miller JM; Nogami A; Patel AR; Pathak RK; Sáenz Morales LC; Santangeli P; Sapp JL; Sarkozy A; Soejima K; Stevenson WG; Tedrow UB; Tzou WS; Varma N; Zeppenfeld K;
    Europace; 2019 Aug; 21(8):1143-1144. PubMed ID: 31075787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
    ; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
    Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.
    Patel D; Hasselblad V; Jackson KP; Pokorney SD; Daubert JP; Al-Khatib SM
    J Interv Card Electrophysiol; 2016 Mar; 45(2):111-7. PubMed ID: 26695501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of long-term mortality after catheter ablation of ventricular tachycardia in a contemporary cohort of patients with structural heart disease.
    Darma A; Bertagnolli L; Dinov B; Torri F; Shamloo AS; Lurz JA; Dagres N; Husser-Bollmann D; Bollmann A; Hindricks G; Arya A
    Europace; 2020 Nov; 22(11):1672-1679. PubMed ID: 32830252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary.
    Cronin EM; Bogun FM; Maury P; Peichl P; Chen M; Namboodiri N; Aguinaga L; Leite LR; Al-Khatib SM; Anter E; Berruezo A; Callans DJ; Chung MK; Cuculich P; d'Avila A; Deal BJ; Della Bella P; Deneke T; Dickfeld TM; Hadid C; Haqqani HM; Kay GN; Latchamsetty R; Marchlinski F; Miller JM; Nogami A; Patel AR; Pathak RK; Saenz Morales LC; Santangeli P; Sapp JL; Sarkozy A; Soejima K; Stevenson WG; Tedrow UB; Tzou WS; Varma N; Zeppenfeld K
    Europace; 2020 Mar; 22(3):450-495. PubMed ID: 31995197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary.
    Cronin EM; Bogun FM; Maury P; Peichl P; Chen M; Namboodiri N; Aguinaga L; Leite LR; Al-Khatib SM; Anter E; Berruezo A; Callans DJ; Chung MK; Cuculich P; d'Avila A; Deal BJ; Della Bella P; Deneke T; Dickfeld TM; Hadid C; Haqqani HM; Kay GN; Latchamsetty R; Marchlinski F; Miller JM; Nogami A; Patel AR; Pathak RK; Saenz Morales LC; Santangeli P; Sapp JL; Sarkozy A; Soejima K; Stevenson WG; Tedrow UB; Tzou WS; Varma N; Zeppenfeld K
    Heart Rhythm; 2020 Jan; 17(1):e155-e205. PubMed ID: 31102616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome.
    Proietti R; Essebag V; Beardsall J; Hache P; Pantano A; Wulffhart Z; Juta R; Tsang B; Joza J; Nascimento T; Pegoraro V; Khaykin Y; Verma A
    Europace; 2015 Mar; 17(3):461-7. PubMed ID: 25488957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
    Cronin EM; Bogun FM; Maury P; Peichl P; Chen M; Namboodiri N; Aguinaga L; Leite LR; Al-Khatib SM; Anter E; Berruezo A; Callans DJ; Chung MK; Cuculich P; d'Avila A; Deal BJ; Della Bella P; Deneke T; Dickfeld TM; Hadid C; Haqqani HM; Kay GN; Latchamsetty R; Marchlinski F; Miller JM; Nogami A; Patel AR; Pathak RK; Saenz Morales LC; Santangeli P; Sapp JL; Sarkozy A; Soejima K; Stevenson WG; Tedrow UB; Tzou WS; Varma N; Zeppenfeld K
    Heart Rhythm; 2020 Jan; 17(1):e2-e154. PubMed ID: 31085023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catheter ablation of ventricular tachycardias in patients with ischemic cardiomyopathy].
    Bourier F; Busch S; Sommer P; Maurer T; Althoff T; Shin DI; Duncker D; Johnson V; Estner H; Rillig A; Bertagnolli L; Iden L; Deneke T; Tilz R; Metzner A; Chun J; Steven D
    Herzschrittmacherther Elektrophysiol; 2022 Mar; 33(1):88-97. PubMed ID: 35157112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of scar based ventricular tachycardia - Procedural characteristics and outcomes.
    Yadav A; Ramasamy S; Theodore J; Anantharaj A; Pillai AA; Satheesh S; Selvaraj RJ
    Indian Heart J; 2020; 72(6):563-569. PubMed ID: 33357646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive substrate ablation in chronic post-myocardial infarction patients with high-risk scar characteristics for ventricular arrhythmias: rationale and design of PREVENT-VT study.
    Falasconi G; Penela D; Soto-Iglesias D; Francia P; Teres C; Viveros D; Bellido A; Alderete J; Meca-Santamaria J; Franco P; Ordoñez A; Díaz-Escofet M; Matiello M; Maldonado G; Scherer C; Huguet M; Cámara Ó; Ortiz-Pérez JT; Martí-Almor J; Berruezo A
    J Interv Card Electrophysiol; 2023 Jan; 66(1):39-47. PubMed ID: 36227461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary.
    Cronin EM; Bogun FM; Maury P; Peichl P; Chen M; Namboodiri N; Aguinaga L; Leite LR; Al-Khatib SM; Anter E; Berruezo A; Callans DJ; Chung MK; Cuculich P; d'Avila A; Deal BJ; Della Bella P; Deneke T; Dickfeld TM; Hadid C; Haqqani HM; Kay GN; Latchamsetty R; Marchlinski F; Miller JM; Nogami A; Patel AR; Pathak RK; Saenz Morales LC; Santangeli P; Sapp JL; Sarkozy A; Soejima K; Stevenson WG; Tedrow UB; Tzou WS; Varma N; Zeppenfeld K
    J Interv Card Electrophysiol; 2020 Oct; 59(1):81-133. PubMed ID: 31960344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.
    Cronin EM; Bogun FM; Maury P; Peichl P; Chen M; Namboodiri N; Aguinaga L; Leite LR; Al-Khatib SM; Anter E; Berruezo A; Callans DJ; Chung MK; Cuculich P; d'Avila A; Deal BJ; Bella PD; Deneke T; Dickfeld TM; Hadid C; Haqqani HM; Kay GN; Latchamsetty R; Marchlinski F; Miller JM; Nogami A; Patel AR; Pathak RK; Saenz Morales LC; Santangeli P; Sapp JL; Sarkozy A; Soejima K; Stevenson WG; Tedrow UB; Tzou WS; Varma N; Zeppenfeld K
    J Interv Card Electrophysiol; 2020 Oct; 59(1):145-298. PubMed ID: 31984466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Catheter ablation of ventricular tachycardia : What have we achieved?].
    Konrad T; Hoffmann BA; Rostock T
    Herz; 2017 Apr; 42(2):132-137. PubMed ID: 28229198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease.
    Makimoto H; Nakajima I; Miyamoto K; Yamada Y; Okamura H; Noda T; Aiba T; Kamakura S; Kusano K; Shimizu W; Satomi K
    Pacing Clin Electrophysiol; 2015 May; 38(5):630-40. PubMed ID: 25639823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catheter ablation of ventricular tachycardia in patients with structural heart disease].
    Lindemann F; Darma A; Hindricks G
    Herz; 2022 Apr; 47(2):129-134. PubMed ID: 35262743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device.
    Aryana A; Gearoid O'Neill P; Gregory D; Scotti D; Bailey S; Brunton S; Chang M; d'Avila A
    Heart Rhythm; 2014 Jul; 11(7):1122-30. PubMed ID: 24732372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.